Title : Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia.

Pub. Date : 2016

PMID : 27867811






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia. Phosphorus fibroblast growth factor 23 Homo sapiens
2 INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract. Phosphorus fibroblast growth factor 23 Homo sapiens
3 INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract. Phosphorus fibroblast growth factor 23 Homo sapiens
4 CONCLUSIONS: We should be aware of the possibility that phosphorus replacement therapy exert marked beneficial effects for the reduction of bone pain in subjects with FGF23-related hypophosphatemic osteomalacia even when we fail to identify tumor localization. Phosphorus fibroblast growth factor 23 Homo sapiens